Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10627547 | 0.82 | ALDH1A1 (0.52) | ALDH1A1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL27521078 | 0.81 | L3MBTL1 (0.55) | TDP1L3MBTL1ALDH1A1NPC1RAB9A | |
| SCHEMBL27666370 | 0.78 | NPSR1 (0.38) | TDP1L3MBTL1ALDH1A1NPC1RAB9A | |
| SCHEMBL10626822 | 0.78 | TDP1 (0.47) | TDP1L3MBTL1ALDH1A1NPC1RAB9A | |
| SCHEMBL6691760 | 0.76 | NPSR1 (0.36) | TDP1L3MBTL1ALDH1A1NPC1RAB9A | |
| SCHEMBL2068767 | 0.76 | NPSR1 (0.43) | TDP1L3MBTL1ALDH1A1NPC1RAB9A | |
| SCHEMBL11449286 | 0.76 | NPSR1 (0.43) | TDP1L3MBTL1ALDH1A1NPC1RAB9A | |
| SCHEMBL8979288 | 0.76 | L3MBTL1 (0.52) | TDP1L3MBTL1ALDH1A1NPC1RAB9A | |
| SCHEMBL76489 | 0.75 | ALDH1A1 (0.67) | TDP1ALDH1A1NPC1RAB9AMEN1 | |
| SCHEMBL8074109 | 0.75 | ALDH1A1 (0.52) | L3MBTL1ALDH1A1NPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1148424-C | Coatable biocidal composition | 3M | 2004-05-05 | — | — | CN | claimed |
| EP-0861302-B1 | COATABLE BIOCIDAL COMPOSITIONS | MINNESOTA MINING & MFG (US) | 2001-11-07 | — | — | EP | claimed |
| EP-0861302-A1 | COATABLE BIOCIDAL COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-09-02 | — | — | EP | claimed |
| CN-1190422-A | Coatable biocidal composition | MINNESOTA MINING & MFG (US) | 1998-08-12 | — | — | CN | claimed |
| WO-1997003135-A1 | COATABLE BIOCIDAL COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-01-30 | — | — | WO | claimed |
| US-5585407-A | SUSTAINED RELEASE OF MICROBIOCIDES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-12-17 | — | — | US | claimed |
| US-9420780-B2 | Composition, method for producing the composition, and phytosanitary formulation containing same | RHODIA OPERATIONS (FR) | 2016-08-23 | — | — | US | disclosed |
| US-9090538-B2 | Uses of esteramide compounds | RHODIA OPERATIONS (FR) | 2015-07-28 | — | — | US | disclosed |
| US-8981148-B2 | Esteramide compounds, methods for preparing same, and uses thereof | RHODIA OPERATIONS (FR) | 2015-03-17 | — | — | US | disclosed |
| US-20140256554-A1 | COMPOSITION, METHOD FOR PRODUCING THE COMPOSITION, AND PHYTOSANITARY FORMULATION CONTAINING SAME | RHODIA OPERATIONS (FR) | 2014-09-11 | — | — | US | disclosed |
| CN-103874410-A | Composition, method for producing the composition, and phytosanitary formulation containing same | RHODIA OPERATIONS | 2014-06-18 | — | — | CN | disclosed |
| US-20130210933-A1 | NOVEL USES OF ESTERAMIDE COMPOUNDS | RHODIA OPERATIONS (FR) | 2013-08-15 | — | — | US | disclosed |
| US-20130210634-A1 | NOVEL ESTERAMIDE COMPOUNDS, METHODS FOR PREPARING SAME, AND USES THEREOF | RHODIA OPERATIONS (FR) | 2013-08-15 | — | — | US | disclosed |
| CN-1148424-C | Coatable biocidal composition | 3M | 2004-05-05 | — | — | CN | disclosed |
| EP-0861302-B1 | COATABLE BIOCIDAL COMPOSITIONS | MINNESOTA MINING & MFG (US) | 2001-11-07 | — | — | EP | disclosed |
| EP-0861302-A1 | COATABLE BIOCIDAL COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-09-02 | — | — | EP | disclosed |
| CN-1190422-A | Coatable biocidal composition | MINNESOTA MINING & MFG (US) | 1998-08-12 | — | — | CN | disclosed |
| WO-1997003135-A1 | COATABLE BIOCIDAL COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-01-30 | — | — | WO | disclosed |
| US-5585407-A | SUSTAINED RELEASE OF MICROBIOCIDES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-12-17 | — | — | US | disclosed |
| US-4867972-A | Novel surface-active compositions containing polydicarboxylic acid polymer and surfactant | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1989-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256554-A1 | COMPOSITION, METHOD FOR PRODUCING THE COMPOSITION, AND PHYTOSANITARY FORMULATION CONTAINING SAME | C1R, CNR2, SRR | TDP1 4386/4885L3MBTL1 4672/4885ALDH1A1 4285/4885 |
| US-20130210933-A1 | NOVEL USES OF ESTERAMIDE COMPOUNDS | CECR2, CES2, ERLIN2 | TDP1 4156/4885L3MBTL1 2694/4885ALDH1A1 4066/4885 |
| US-20130210634-A1 | NOVEL ESTERAMIDE COMPOUNDS, METHODS FOR PREPARING SAME, AND USES THEREOF | CNR2, CRHR2, HRH3 | TDP1 4678/4885L3MBTL1 4256/4885ALDH1A1 2758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.